CATHERINE M VACZY
CIK 1177176 · EVP GC Chief Strategy Officer · last filed 2023-04-24
CATHERINE M VACZY is an EVP GC Chief Strategy Officer who has filed 29 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing shows the insider bought $21.5K of GNPX on Apr 24, 2023. Across all open-market trades the lifetime net is +$21.5K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $169.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$169.7K
4
29
$21.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GNPX | EVP GC Chief Strategy Officer | 265,000 | $0.64 | $169.7K | $21.5K | 4 | 2023-04-24 |
| LISATA THERAPEUTICS, INC. (NBS) Delisted | General Counsel | 71,234 | — | — | $0 | 9 | 2015-04-14 |
| LISATA THERAPEUTICS, INC. (NBS.WS) Delisted | VP and General Counsel | 345,362 | — | — | $0 | 14 | 2012-06-27 |
| LISATA THERAPEUTICS, INC. (NBS.U) Delisted | VP and General Counsel | 123,772 | — | — | $0 | 1 | 2007-10-01 |
Recent Filings
29 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-04-24 | GNPX | Buy (P) | +20,000 | $21.5K | EDGAR |
| 2023-02-22 | GNPX | Grant (A) | +245,000 | $0 | EDGAR |
| 2022-02-08 | GNPX | Grant (A) | — | $0 | EDGAR |
| 2021-03-23 | GNPX | Grant (A) | — | $0 | EDGAR |
| 2015-04-14 | LISATA THERAPEUTICS, INC. (NBS) Delisted | Grant (A) | +3,971 | $0 | EDGAR |
| 2015-02-06 | LISATA THERAPEUTICS, INC. (NBS) Delisted | Mixed | +17,904 | -$42.8K | EDGAR |
| 2015-01-02 | LISATA THERAPEUTICS, INC. (NBS) Delisted | Grant (A) | +962 | $3.1K | EDGAR |
| 2014-08-01 | LISATA THERAPEUTICS, INC. (NBS) Delisted | Grant (A) | +11,756 | $0 | EDGAR |
| 2014-07-01 | LISATA THERAPEUTICS, INC. (NBS) Delisted | Grant (A) | +556 | $3.1K | EDGAR |
| 2014-01-03 | LISATA THERAPEUTICS, INC. (NBS) Delisted | Grant (A) | +598 | $2.9K | EDGAR |